Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-08-007037
Filing Date
2008-05-29
Accepted
2008-05-29 15:06:35
Documents
3
Period of Report
2008-06-24
Effectiveness Date
2008-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2184974zdef14a.htm DEF 14A 272558
2 G64900.JPG g64900.jpg GRAPHIC 2542
3 G136921.JPG g136921.jpg GRAPHIC 1916
  Complete submission text file 0001047469-08-007037.txt   280569
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-16614 | Film No.: 08866285
SIC: 2835 In Vitro & In Vivo Diagnostic Substances